Haemonetics HAE
NYSE HAE
$100.79 -2.37 (-2.29%)
As of: Sep 10, 2026 · 3:25 PM EDT

Haemonetics (HAE) Net Income Growth (1y) (2010 - 2026)

Analysis

Haemonetics (HAE) Net Income Growth (1y) (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (1y) (Qtr)
1 Abbott Laboratories 180.08 Bn 174.48 Bn 7.27 Bn -47.84%
2 Intuitive Surgical 127.86 Bn 122.64 Bn 1.96 Bn 23.94%
3 Medtronic 117.15 Bn 108.33 Bn 6.34 Bn 41.36%
4 Stryker 103.82 Bn 100.34 Bn 4.50 Bn 44.34%
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn 13.84%
6 Edwards Lifesciences 49.76 Bn 45.51 Bn 1.35 Bn -27.18%
7 Alcon 32.95 Bn 31.49 Bn 1.68 Bn -141.44%
8 Dexcom 32.22 Bn 30.27 Bn 830.00 Mn 38.54%
9 Steris 20.71 Bn 20.23 Bn 684.20 Mn 12.92%
10 Haemonetics 4.58 Bn 4.36 Bn 202.80 Mn -3.11%
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 -3.11%
Mar 28, 2026 -134.70%
Dec 27, 2025 19.33%
Sep 27, 2025 14.44%
Jun 28, 2025 -11.32%
Mar 29, 2025 184.12%
Dec 28, 2024 20.06%
Sep 28, 2024 35.72%
Jun 29, 2024 -6.50%
Mar 30, 2024 -30.65%
Dec 30, 2023 -5.15%
Sep 30, 2023 -24.88%
Jul 1, 2023 106.48%
Apr 1, 2023 201.07%
Dec 31, 2022 41.99%
Oct 1, 2022 123.71%
Jul 2, 2022 546.27%
Apr 2, 2022 188.52%
Jan 1, 2022 -27.25%
Oct 2, 2021 -69.16%